Eric Swayze, EVP Research at IONIS PHARMACEUTICALS INC (IONS), sold 3,630 shares at $40.79 ($148K) on 2023-02-06, disclosed to the SEC on 2023-02-07.
Open-market sale of $148k IONS by EVP Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.79 | 1,815 | $74K | 50.0% |
| 2 | $40.79 | 1,815 | $74K | 50.0% |
| Total | $40.79 avg | 3,630 | $148K | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $512K | — | Filing → |
| IONS | SELL | 2026-01-20 | $748K | — | Filing → |
| IONS | SELL | 2026-01-06 | $1.9M | — | Filing → |